CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
-0.0074 (-6.30%)
At close: Mar 27, 2026
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $2.26 million as of March 27, 2026. Its market cap has decreased by -92.95% in one year.
Market Cap
2.26M
Enterprise Value
16.43M
Revenue
26.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from 101.76M to 2.26M, a decrease of -97.78%. That is a compound annual growth rate of -11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.26M | -87.05% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 3.19M |
| Oncology Pharma | 2.94M |
| Clearside Biomedical | 2.83M |
| Burzynski Research Institute | 2.67M |
| VitaSpring Biomedical | 2.30M |
| AXIM Biotechnologies | 2.22M |
| Exousia Pro | 1.89M |
| ProtoKinetix | 1.88M |